By Moderna Therapeutics | November 17, 2017Moderna Initiates Dosing Regimen for Phase I Study of Personalized Cancer Vaccine
By Moderna Therapeutics | November 3, 2017Moderna, AstraZeneca to Collaborate on Developing Relaxin mRNA Therapeutic for Heart Failure
